Startseite Medizin Plasma free fatty acids in hyperemesis gravidarum pregnancy
Artikel Open Access

Plasma free fatty acids in hyperemesis gravidarum pregnancy

  • Mustafa Ulubay EMAIL logo , Mustafa Ozturk , Ozlem Ozturk , Ugur Keskin , Ulas Fidan , Erdim Sertoglu , Hakan Aydin , Ali Yilmaz und Mufit Cemal Yenen
Veröffentlicht/Copyright: 4. Mai 2017

Abstract

We evaluated the free fatty acids differences in plasma between hyperemesis gravidarum(HG) and healthy pregnant in first trimester pregnancy.

Objective

We aimed to compare the plasma levels of DHA, AA and EPA, between HG patients and healthy pregnant women

Design

Fifty-two pregnants were involved in the study. Twenty-six pregnants of them were HG as study group, and twenty-six pregnants were enrolled as healthy pregnant women at the similar gestational age. The saturated fatty acids C14, C15, C16, C18, C20, C22, and C24; the omega-3 fatty acids eicosapentaenoic acid, (EPA) and docosahexaenoic acid, (DHA); the omega-6 fatty acids linoleic acid, arachidonic acid (AA), and homo-gamma-linolenic acid; and the omega-9 fatty acids oleic acid, erucic acid, and nervonic acid were analysed by gas chromatography.

Results

Statistically differences was not seen between the groups with maternal age, gestational age, or plasma levels of EPA, DHA, and AA. Statistically significant difference was seen between the groups with plasma levels of C20 and C22(p<0.05). C20 was declined but C22 was rised in the HG patients.

Conclusion

EPA, DHA, or AA, which related to placental and fetal neural development are not changing from Hyperemesis gravidarum.

1 Introduction

Nausea and vomiting are common in pregnancy, occurring in 70–85% of all gravid women [1]. Hyperemesis gravidarum (HG) is a complication of pregnancy characterized by extreme nausea, vomiting, and dehydration in the first trimester [2, 3]. HG causes uncontrolled vomiting requiring hospitalization, severe dehydration, muscle wasting, electrolyte imbalance, ketonuria, and loss of more than 5% of the body weight [4]. HG occurs in 0.3–2.0% of pregnancies [5], differs from the common nausea and vomiting experienced during pregnancy, and often requires hospitalization. Starvation is commonly seen in patients with HG [6].

Lipolysis, the removal of fatty acid chains from the glycerol to which they are bound in their storage form as triglycerides, is carried out by lipases. Fatty acids are then broken down to acetyl-CoA by means of beta oxidation inside the mitochondria. Under fasting conditions, adipose tissue initiates lipolysis and produces glycerol and free fatty acids (FFAs). The maternal liver converts these FFAs to glycerol and ketone to glucose, which can cross the placenta to maintain fetal metabolism [7]. FFAs are required as a source of energy for the development of the fetus and are used for maintaining the fluidity, permeability, and conformation of membranes; they are the precursors of prostacyclins, prostaglandins, thromboxanes, and leukotrienes [8]. Therefore, accurate measurement of plasma FFAs has important physiological and clinical implications. To understand and decrease the effects of HG-caused dehydration, muscle wasting, electrolyte imbalance, ketonuria and weight loss, we wish to evaluate which FFAs are used as an energy source in pregnant women with HG.

Essential fatty acids (EFAs), such as α-linolenic acid (ALA), linoleic acid (LA), and their long-chain derivatives, can act as energy sources, but their main functions are structural and metabolic [8]. EFAs cannot be produced by mammalian tissues because of the need for desaturase enzymes and must be acquired through dietary intake [9]. Although the human body cannot produce de novo omega-3 and omega-6 long-chain polyunsaturated fatty acids (LC-PUFAs) [10], it can desaturate and elongate them by way of other enzymes, transforming LA to arachidonic acid (AA; 20:4n-6) and ALA to docosahexaenoic acid (DHA; 22:6n-3) and eicosapentaenoic acid (EPA; 20:5n-3) [11]. All the omega-3 and omega-6 fatty acids needed by the fetus must be supplied by the mother [12].

The most biologically important omega fatty acids are omega-3 (EPA and DHA) and omega-6 (AA) [13, 14]. These mediate a number of key biological processes, including cell membrane physiology, signaling pathways, inflammation, gene regulation, and expression. They also have important functions in fetal and newborn neural development [15-17].

This prospective case-control study examined women in the first trimester of pregnancy to compare plasma FFAs and plasma levels of DHA, AA, EPA, and other fatty acids in HG patients and healthy pregnant women.

2 Materials and methods

2.1 Subjects

Ethical permission for this study was obtained through the Gulhane Military Medical Academy Ethics Committee (GATA KAEK-14047). The patients were informed about the examination process, and their consent was obtained. The study was carried out over a 16-month period (January 2013–April 2014).

2.2 Clinical studies

Twenty-six women with normal pregnancies (control group) and 26 women with pregnancies complicated by HG, ketonuria, and weight loss of more than 5% of body weight were enrolled in the study. Gestational age was confirmed by obstetric ultrasonography to be between 7 and 12 weeks. The exclusion criteria were fetal malformation, maternal disease, diabetes, alcohol abuse, or infection. All were singleton pregnancies, and none of the women were smokers. Maternal venous blood and urine samples were taken from all patients in the morning.

2.3 Assessment of dietary fatty acid intake

Measuring dietary fat intake can be difficult with use of food-frequency questionnaires (FFQs). Biological markers are more objective than FFQs, because biological markers do not depend on food-intake composition databases or the appropriateness of FFQ items (18). Levels of erythrocytes and C15 (pentadecanoic acid) in plasma can be used as diagnostic markers of dietary fat intake [19].

2.4 Biochemical analysis

Biochemical analysis was performed as described by Folch et al. [20]. Blood samples were collected in ethylenediaminetetraacetic acid (EDTA) tubes and kept on ice. Plasma for fatty acid analysis was separated by centrifugation at 3,000 rpm for 10 min. at 4°C and then frozen at −80°C until analysis. Lipids were extracted from 0.20 mL of plasma in chloroformmethanol (2:1) containing 10 mg/L of butylated hydroxytoluene (BHT) [20]. Thin-layer chromatography (Hewlett-Packard 6890 gas chromatograph; Minnesota, USA) was used to separate and evaporate plasma phospholipids until dry under nitrogen gas. Fatty acids were classified against authentic lipid standards obtained from Nu-Chek Prep, Inc. (Elysian, MN, USA). We evaluated the saturated fatty acids (SFAs) C14 (myristic acid), C15 (pentadecanoic acid), C16 (palmitic acid), C18 (stearic acid), C20 (arachidic acid), C22 (behenic acid), and C24 (lignoceric acid); the omega-3 FFAs C22:5n3 (EPA) and C22:6n3 (DHA); the omega-6 FFAs C18:2n6 (LA), C20:4n6 (AA), and C20:3n6 (homo-gamma-linolenic acid); and the omega-9 FFAs C18:1n9 (oleic acid), C22:1n9 (erucic acid), and C24:1n9 (nervonic acid) (Table 1).

Table 1

Demographic characteristics of the participants and measurements of plasma free fatty acids for the control and hyperemesis gravidarum groups

Plasma Free Fatty Acids (μg/mL)Hyperemesis GravidarumControl Groupp
n=26 Mean±Sd (Min-Max)-(Median)n=26 Mean±Sd (Min-Max)-(Median)
Age28±1 (22–35) 28±3 (22–36) 0,876
Gestatinoal age (week)8±0,67,8±0,80,585
C15 (Pantadecanoic acid)6.0 ± 6.1 (1.1–17.4)–(1.1)8.8 ± 7.9 (1.1–34.6)–(9.3)0,244
C20:4n6 (AA Arachidonic acid )232.0 ± 21.6 (193–292)–(228)237.4 ± 25.9 (19.6–279)–(234)0,426
C22:5n3 (EPA Eicosapentaenoic acid)47.9 ± 21.5 (0.4–68)–(53.9)35.0 ± 30.4 (0.4–66.6)–(55.7)0,566
C22:6n3 (DHA Docosahexaenoic acid)79.0 ± 44.5 (0.7–118.5)–(101.2)60 ± 49 (0.7–119)–(84.1)0,082
C14 (Miristic acid)102.5±79 (3.1–247)–(137.2)112.7±78 (3.1–247)–(140)0,297
C16 (Palmitic acid)1115.9±264 (724–1762)–(1070)1045.9±222 (706–1942)–(1038)0,341
C18 (Stearic acid)459.5±186 (35–752)–(482)543.9±145 (69–775)–(549)0,085
C18:1n9 (Oleic acid)1026.9±157 (793–1362)–(1009)1023.9±120 (709–1220)–(1034)0,770
C18:2n6 (Linoleic acid)1379.9±162 (1087–1714)–(1387)1406.2±173 1027–1753)–(1410)0,546
C20 (Arachidic acid)18.5±7 (0.4–28.6)–(20.1)22.1±3 (15.8–28.4)–(21.5)0,039[*]
C22 (Behenic acid)39.7±9.5 (0.8–53.3)–(40.2)25.7±20 (0.8–66.5)–(33.5)0,001[*]
C20:3n6 (Homogamma-linolenic acid)67.5±46 (0.4–111.3)–(91.9)80.3±48 (0.4–124.6)–(95.3)0,361
C22:1n9 (Erucic asit)5.6±4.3 (0.3–12.7)–(7.0)3.0±4.3 (0.3–11.6)–(0.3)0,066
C24 (Lignoceric asit)28.8±14 (1–42.2)–(33.7)26.8±15 (1.0–42.9)–(32.9)0,538
C24:1 (Nervonic asit)39.5±17 (0.6–55.1)–(46)30.8±24 (0.6–59)–(45.2)0,839

2.5 Statistical analysis

Data were presented as mean ± standard deviation and analyzed with SPSS version 15 (SPSS Inc., Chicago, IL, USA). The relationships between the study and control groups were assessed with Mann–Whitney U tests. A level of significance equal to or less than 0.05 was used to determine statistical significance.

3 Results

The average gestational age of the HG group was 9.2 ± 1.2 weeks. In the control group, the average gestational age was 8.8 ± 1 weeks (p > 0.05). The mean ages of the group of HG patients and the control group were 28 years and 26 years, respectively (p > 0.05). No statistical difference was observed between the groups as far as maternal or gestational age.

We found no significant difference between the groups in the levels of myristic acid, pentadecanoic acid, palmitic acid, stearic acid, lignoceric acid, EPA, DHA, LA, AA, homo-gamma-linolenic acid, oleic acid, erucic acid, or nervonic acid (p > 0.05). In the HG and control groups, respectively, pentadecanoic acid was 6.5 ± 7.6 and 9.1 ± 6.0;AA was 236.68 ± 22.7 and 231.4 ± 25.8; EPA was 41.28 ± 26.0 and 41.9 ± 29.17; and DHA was 65.23 ± 50.6 and 76.8 ± 42.4.

Between the HG and control groups, we found a statistical difference in the levels of arachidic acid (18.5 ± 7 and 22.1 ± 3, p = 0.039) and behenic acid (39.7 ± 9.5 and 25.7 ± 20, p = 0.001), respectively (Tables 1 and 2). The level of arachidic acid was lower in the HG group, while behenic acid was higher.

Table 2

Correlation analysis of groups (hyperemesis gravidarum [HG] and control group) with C20 and C22

Correlation (HG and Control)
rp
C20 (Arachidic acid)0.2900.037
C22 (Behenic acid)−0.4570.001

Spearman correlation test

None of the patients in either group had any pregnancy complications.

4 Discussion

In some studies, improper maternal diet and weight loss have been seen to cause complications, such as low birth weight, antepartum hemorrhage, preterm birth, and fetal abnormality [21], while other studies have shown no difference in adverse fetal outcomes between women diagnosed with HG and normal pregnant women [22-24]. Fatty acid degradation, accompanied by ketosis, is dependent on the hunger level of pregnant women with HG. In all pregnancies, the fetus obtains EFAs from the mother by placental transfer [25]. In this study, we aimed to detect which FFAs in plasma undergo lipolysis to produce ketone bodies and, especially, to identify the omega-3 and omega-6 FFAs used for lipolysis.

FFA levels in plasma and in the erythrocyte membrane (EM) have been studied previously [26]. The EM is a better source than plasma to measure fatty acids to gain information about long-term fat intake [27], in part because of the lower sensitivity and slower turnover rate of EM FFAs [28]. We evaluated the FFAs in plasma to look at shorter-term intake because our patients were in the first trimester of pregnancy and their problems had started only a few weeks before.

There is a positive correlation between birth weight and LC-PUFA concentrations in maternal plasma during the first trimester of pregnancy [29]. Heird et al. reported that AA is necessary for fetal growth [30], and Innis reported that DHA has an important function in retinal and brain development and function during the neonatal period [31]. Crawford et al. also reported that the dietary EFAs LA and α-linolenic acid (ALA) and their LC-PUFA products, mainly AA and DHA, are essential to brain and retinal development [32]. DHA is known to have an important function as a structural component in the retina and nervous system, because a deficiency of omega-3 fatty acids in the diet during the antenatal and postnatal period causes irreversible neuronal and visual deterioration [33]. DHA is found in the membranes of neuronal synapses and photoreceptor segments [34-36]. In early pregnancy, DHA is an important factor for fetal growth and development and also functions as a vascular remodeling and placental angiogenic factor [37]. Although many researchers have studied the concentrations of LC-PUFAs in maternal plasma, no studies have been carried out on HG patients to examine their levels of AA, DHA, and EPA fatty acids.

Adaptations in maternal metabolism result in the transport of maternal nutrients from the placenta to the fetus for fetal growth [38]. Our findings showed no statistical difference between the HG and control groups in maternal plasma levels of the SFAs myristic acid, pentadecanoic acid, palmitic acid, stearic acid, and lignoceric acid; the mono-unsaturated fatty acids oleic acid, erucic acid, and nervonic acid; the omega-3 fatty acids EPA and DHA; or the omega-6 fatty acids LA, AA, and homo-gamma-linolenic acid. Our study demonstrated that the fetus did not waste the necessary nutrients, especially AA, DHA, and EPA, even when maternal malnutrition and fatty acid degradation occurred in the first trimester of pregnancy.

Which fatty acids are used to produce ketone bodies by lipolysis in the hyperemetic pregnancy? We found that the long-chain SFA arachidic acid was present at lower levels in the HG group (p < 0.05), which indicates that it is used for producing ketone bodies; it would provide more energy than short- and medium-chain fatty acids. Although there were no comparable data found in the literature, our results provide evidence that arachidic acid is used to produce ketone bodies as an energy source in cases of maternal malnutrition caused by HG. The long-chain SFAs arachidic acid, behenic acid, and lignoceric acid are derived from dietary sources and may also be produced endogenously by the elongation of stearic acid (39). Long-chain SFAs exhibit distinct functions when compared to other long-chain SFAs; for example, they are known to influence liver homeostasis, retinal function, and anti-inflammatory functions [40].

Interestingly, we also found that the level of behenic acid was higher in the HG group than the control group. The reason for this is unclear. Behenic acid is a cholesterol-raising SFA in humans [41]. Although the mechanism requires further elucidation, Cater et al.’s findings indicate that dietary behenic acid is particularly potent in raising concentrations of total and LDL cholesterol [41]. Elevated levels of behenic acid may increase cholesterol synthesis in the fetus. The higher level of behenic acid in the HG group needs further investigation. In the future, it may also be useful to compare levels of arachidic acid and behenic acid with the severity of symptoms in HG patients.

The main limitation of our study was the small number of participants in the study group (n = 26) and the control group (n = 26).

5 Conclusion

Levels of plasma DHA, EPA, AA, and other FFAs were not affected by HG, but the level of the saturated long-chain FFA arachidic acid was reduced in HG patients compared with women having a normal pregnancy, although behenic acid was elevated.

  1. Conflict of interest: No authors report any conflict of interest.

References

[1] Bottomley C, Bourne T. Management strategies for hyperemesis. Best Pract Res Clin Obstet Gynaecol. 2009 Aug. 23(4):549-56410.1016/j.bpobgyn.2008.12.012Suche in Google Scholar

[2] Arsenault MY, Lane CA, MacKinnon CJ, Bartellas E, Cargill YM, Klein MC, Martel MJ, Sprague AE, Wilson AK. The management of nausea and vomiting of pregnancy. J. Obstet Gynaecol Can. 2002;24(10):817-83110.1016/S1701-2163(16)30475-3Suche in Google Scholar

[3] Goodwin TM. Hyperemesis gravidarum. Obstetrics and Gynecology Clinics of North America. 2008;35(3):401-41710.1016/j.ogc.2008.04.002Suche in Google Scholar

[4] Levine MG, Esser D. Total parental nutrition for the treatment of severe hyperemesis gravidarum: maternal nutritional effects and fetal outcome. Obstet Gynecol. 1988;72:102-107Suche in Google Scholar

[5] Bailit JL. Hyperemesis gravidarum: epidemiologic findings from a large cohort. Am J Obstet Gynecol. 2005.193:811-81410.1016/j.ajog.2005.02.132Suche in Google Scholar

[6] Outlaw WM, Ibdah JA. Impaired fatty acid oxidation as a cause of liver disease associated with hyperemesis gravidarum. Med Hypotheses. 2005;65(6):1150-115310.1016/j.mehy.2005.05.035Suche in Google Scholar

[7] Herrera E. Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development – a review. Placenta 23, supplement A Trophoblast research 2002:16, S9-S1910.1053/plac.2002.0771Suche in Google Scholar

[8] Haggerty P. Effect of placental function on fatty acid requirements during pregnancy. Eur J Clin Nutr. 2004;58:1559-157010.1038/sj.ejcn.1602016Suche in Google Scholar

[9] Calder PC. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale? Nutr Res 2001, 21:309-34110.1016/S0271-5317(00)00287-6Suche in Google Scholar

[10] Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003, 143:1-810.1067/S0022-3476(03)00396-2Suche in Google Scholar

[11] Innis SM. Essential fatty acid transfer and fetal development. Placenta 2005 26:570-57510.1016/j.placenta.2005.01.005Suche in Google Scholar PubMed

[12] Greenberg JA, Bell SJ, Ausdal WV. Omega-3 Fatty Acid supplementation during pregnancy. Rev Obstet Gynecol. 2008 Fall;1(4):162-169Suche in Google Scholar

[13] Haggarty P. Fatty acid supply to the human fetus. Annual Review of Nutrition 2010:30 237–255. (10.1146/annurev.nutr.012809.104742)Suche in Google Scholar

[14] Friedman A.N., Yu Z., Tabbey R., Denski C., Tamez H., Wenger J. Low Blood Levels of Long-Chain n–3 Polyunsaturated Fatty Acids in US Hemodialysis Patients: Clinical Implications. Am J Nephrol. 2012:36:451-45810.1159/000343741Suche in Google Scholar

[15] Birch EE, Garfield S, Castaneda Y, Birch DG, Uauy R, Hoffman DR. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of longchain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev. 2007;83: 279-28410.1016/j.earlhumdev.2006.11.003Suche in Google Scholar

[16] Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr. 2001;73:807-81410.1093/ajcn/73.4.807Suche in Google Scholar

[17] Innis SM, Friesen RW. Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr. 2008;87: 548-55710.1093/ajcn/87.3.548Suche in Google Scholar

[18] Cantwell MM. Assessment of individual fatty acid intake. Proc Nutr Soc 2000;59:187-19110.1017/S0029665100000203Suche in Google Scholar

[19] Sun Q, Ma J, Campos H, Hu FB. Plasma and erythrocyte biomarkers of dairy fat intake and risk ofischemic heart disease. Am J Clin Nutr 2007;86:929-93710.1093/ajcn/86.4.929Suche in Google Scholar

[20] Folch J, Lees M, Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957 226:497-50910.1016/S0021-9258(18)64849-5Suche in Google Scholar

[21] Veenendaal MV, van Abeelen AF, Painter RC, van der Post JA, Roseboom TJ. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG. 2011;118:1302-131310.1111/j.1471-0528.2011.03023.xSuche in Google Scholar PubMed

[22] Roseboom TJ, Ravelli AC, van der Post JA, Painter. RC Maternal characteristics largely explain poor pregnancy outcome after hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 2011;156(1):56-5910.1016/j.ejogrb.2011.01.010Suche in Google Scholar PubMed

[23] Dodds L, Fell DB, Joseph KS, Allen VM, Butler B. Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and diclectin. J Pediatr. 2009 Jul;155(1):45-5010.1016/j.jpeds.2009.02.005Suche in Google Scholar

[24] Nulman I, Rovet J, Barrera M, Knittel-Keren D, Feldman BM, Koren G. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol. 2006 Feb;107(2 Pt 1):285-29210.1097/01.AOG.0000195060.22832.cdSuche in Google Scholar

[25] Innis SM. Essential fatty acids in growth and development. Prog Lipid Res 1991;30:39-10310.1016/0163-7827(91)90006-QSuche in Google Scholar

[26] Blau N, Duran M, Gibson KM. Laboratory Guide to the Methods in Biochemical Genetics. 207-19. Berlin, 2008. ISBN 978-3-540-76697-1Suche in Google Scholar

[27] Fuhrman B.J. Barba M. Krogh V. Micheli A. Pala V. Lauria R. Chajes V. Riboli E. Sieri S. Berrino F. Muti P. Erythrocyte membrane phospholipid composition as biomarker of dietary fat. Ann Nutr Metab. 2006;50:95-10210.1159/000090496Suche in Google Scholar

[28] Baylin A. Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol. 2006. 17:22-2710.1097/01.mol.0000199814.46720.83Suche in Google Scholar

[29] van Eijsden M, Hornstra G, van der Wal MF, Vrijkotte TG, Bonsel GJ. Maternal essential fatty acid status early in pregnancy and term birthweight: a prospective cohort study. Am J Clin Nutr 2008, 87:887-89510.1093/ajcn/87.4.887Suche in Google Scholar

[30] Heird WC, Lapillonne A. The role of essential fatty acids in development. Annu Rev Nutr 2005, 25:549-55710.1017/CBO9780511544712.014Suche in Google Scholar

[31] Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res 2008, 1237:35-4310.1007/978-0-387-92271-3_133Suche in Google Scholar

[32] Crawford MA, Hassam AG, Williams G. Essential fatty acids and fetal brain growth. Lancet 1976.1:452-45310.1016/S0140-6736(76)91476-8Suche in Google Scholar

[33] Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986;83:4021-402510.1073/pnas.83.11.4021Suche in Google Scholar PubMed PubMed Central

[34] Fliesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983;22:79-131. 210.1016/0163-7827(83)90004-8Suche in Google Scholar

[35] Sastry PS. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 1985;24:69-17610.1016/0163-7827(85)90011-6Suche in Google Scholar

[36] Svennerholm L. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res 1968;9:570-57910.1016/S0022-2275(20)42702-6Suche in Google Scholar

[37] Johnsen GM, Basak S, Weedon-Fekjær MS, Staff AC, Duttaroy A.K. Docosahexaenoic acid stimulates tube formation in first trimester trophoblast cells, HTR8/SVneo. Placenta 2011. 32; 9: 626-63210.1016/j.placenta.2011.06.009Suche in Google Scholar

[38] Villar J, Cogswell M, Kestler E, Castillo P, Menendez R, Repke RT. Effect of fat and fat-free mass deposition during pregnancy on birth weight. Am J Obstet Gynecol 1992.167:1344-135210.1016/S0002-9378(11)91714-1Suche in Google Scholar

[39] Jakobsson A, Westerberg R. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res. 2006; 45:237-24910.1016/j.plipres.2006.01.004Suche in Google Scholar PubMed

[40] Kihara A. Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem. 2012; 152:387-39510.1093/jb/mvs105Suche in Google Scholar PubMed

[41] Cater NB, Denke MA. Behenic acid is a cholesterol-raising saturated fatty acid in humans. Am J Clin Nutr 2001;73:41-4410.1093/ajcn/73.1.41Suche in Google Scholar PubMed

Received: 2016-7-22
Accepted: 2017-2-23
Published Online: 2017-5-4

© 2017 Mustafa Ulubay et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
Heruntergeladen am 25.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/med-2017-0009/html
Button zum nach oben scrollen